Massimo Zeuli

1.3k total citations
37 papers, 917 citations indexed

About

Massimo Zeuli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Massimo Zeuli has authored 37 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Massimo Zeuli's work include Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (6 papers). Massimo Zeuli is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (6 papers). Massimo Zeuli collaborates with scholars based in Italy, Malaysia and United States. Massimo Zeuli's co-authors include F. Cognetti, L. Serrone, Francesco Cognetti, Virginia Ferraresi, Diana Giannarelli, Isabella Sperduti, Carlo Garufi, Angela Torsello, Marcella Mottolese and Giuseppe Maria Ettorre and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Massimo Zeuli

36 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Zeuli Italy 14 546 276 226 159 152 37 917
Katsuyuki Kunieda Japan 13 288 0.5× 164 0.6× 198 0.9× 164 1.0× 48 0.3× 83 697
Yuling Chen Taiwan 17 191 0.3× 106 0.4× 260 1.2× 205 1.3× 70 0.5× 32 701
Preston D. Steen United States 18 579 1.1× 329 1.2× 259 1.1× 120 0.8× 51 0.3× 47 1.0k
Eriko Miyazaki Japan 17 103 0.2× 180 0.7× 256 1.1× 170 1.1× 59 0.4× 55 663
M. Paganuzzi Italy 16 331 0.6× 518 1.9× 257 1.1× 115 0.7× 65 0.4× 38 992
Luca Paoluzzi United States 16 478 0.9× 231 0.8× 505 2.2× 55 0.3× 39 0.3× 41 1.0k
Kanenori Endo Japan 17 365 0.7× 148 0.5× 369 1.6× 332 2.1× 132 0.9× 37 890
Hidekazu Kuramochi Japan 19 626 1.1× 302 1.1× 247 1.1× 272 1.7× 102 0.7× 77 1.0k
Hironori Kusano Japan 15 247 0.5× 164 0.6× 171 0.8× 184 1.2× 228 1.5× 67 721
Shingo Kamoshida Japan 17 311 0.6× 224 0.8× 335 1.5× 170 1.1× 16 0.1× 82 867

Countries citing papers authored by Massimo Zeuli

Since Specialization
Citations

This map shows the geographic impact of Massimo Zeuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Zeuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Zeuli more than expected).

Fields of papers citing papers by Massimo Zeuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Zeuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Zeuli. The network helps show where Massimo Zeuli may publish in the future.

Co-authorship network of co-authors of Massimo Zeuli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Zeuli. A scholar is included among the top collaborators of Massimo Zeuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Zeuli. Massimo Zeuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bazzichetto, Chiara, Michèle Milella, Francesca Simionato, et al.. (2022). Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker. Biomedicines. 10(10). 2631–2631. 19 indexed citations
2.
Bassanelli, Maria, Sara Ramella, Massimo Zeuli, & Anna Ceribelli. (2022). Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC. Anticancer Research. 42(5). 2241–2247. 6 indexed citations
3.
Allegretti, Matteo, Giuliano Cottone, Fabio Carboni, et al.. (2020). Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy. Journal of Experimental & Clinical Cancer Research. 39(1). 69–69. 20 indexed citations
4.
Garufi, Carlo, Elisa Giacomini, Angela Torsello, et al.. (2016). Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC). Scientific Reports. 6(1). 34006–34006. 17 indexed citations
5.
Vaccaro, Vanja, Emilio Bria, Isabella Sperduti, et al.. (2012). Optimizing supportive measures for the safe administration of FOLFIRINOX as first-line treatment in advanced, inoperable pancreatic cancer (aPDAC) patients (pts) in routine clinical practice.. Journal of Clinical Oncology. 30(15_suppl). e14661–e14661. 2 indexed citations
6.
Garufi, Carlo, Angela Torsello, Salvatore Tumolo, et al.. (2010). Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. British Journal of Cancer. 103(10). 1542–1547. 140 indexed citations
7.
Ferraresi, Virginia, Carmen Nuzzo, Carmine Zoccali, et al.. (2010). Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 10(1). 22–22. 96 indexed citations
8.
Nuzzo, Carmen, et al.. (2008). Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.. PubMed. 28(2B). 1429–31.
9.
Ferraresi, Virginia, Mariangela Ciccarese, Maria Cecilia Cercato, et al.. (2008). Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study. Cancer Chemotherapy and Pharmacology. 63(1). 149–155. 24 indexed citations
10.
Torsello, Angela, Carlo Garufi, Maurizio Cosimelli, et al.. (2008). P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance. European Journal of Cancer. 44(9). 1217–1222. 22 indexed citations
11.
Gelibter, Alain, Teresa Gamucci, Francesco Di Costanzo, et al.. (2007). A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer. Current Medical Research and Opinion. 23(9). 2117–2123. 13 indexed citations
12.
Zeuli, Massimo, Maria Simona Pino, Teresa Gamucci, et al.. (2003). Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Annals of Oncology. 14(9). 1378–1382. 46 indexed citations
13.
Serrone, L., Massimo Zeuli, Teresa Gamucci, Marco Nardi, & F. Cognetti. (2001). A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule. Cancer Chemotherapy and Pharmacology. 47(3). 206–210. 11 indexed citations
14.
Serrone, L., et al.. (2001). Ifosfamide and Epirubicin Combination in Untreated Sarcomas: Two Treatment Schedules. Oncology Research and Treatment. 24(5). 465–468. 3 indexed citations
15.
Zeuli, Massimo, et al.. (2001). Capecitabine and oxaliplatin in advanced colorectal cancer: A dose-finding study. Annals of Oncology. 12(12). 1737–1741. 19 indexed citations
16.
Arena, Maria, Cora N. Sternberg, Massimo Zeuli, et al.. (1993). Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer. Annals of Oncology. 4(3). 241–244. 12 indexed citations
17.
Sternberg, Cora N., Maria Arena, F. Calabresi, et al.. (1993). Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder. Cancer. 72(6). 1975–1982. 39 indexed citations
18.
Sternberg, C., Maria Arena, Vito Pansadoro, et al.. (1992). Recombinant tumor necrosis factor for superficial bladder tumors. Annals of Oncology. 3(9). 741–745. 9 indexed citations
19.
Paggi, Marco G., et al.. (1990). Inhibition of protein synthesis in neoplastic cells by rhein. Biochemical Pharmacology. 40(5). 967–973. 7 indexed citations
20.
Paggi, Marco G., Maurizio Fanciulli, Nicola Perrotti, et al.. (1988). The Role of Mitochondrial Hexokinase in Neoplastic Phenotype and Its Sensitivity to Lonidamine a. Annals of the New York Academy of Sciences. 551(1). 358–360. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyuki Kunieda Breakdown of academic impact, for papers by Yuling Chen Breakdown of academic impact, for papers by Preston D. Steen Breakdown of academic impact, for papers by Eriko Miyazaki Breakdown of academic impact, for papers by M. Paganuzzi Breakdown of academic impact, for papers by Luca Paoluzzi Breakdown of academic impact, for papers by Kanenori Endo Breakdown of academic impact, for papers by Hidekazu Kuramochi Breakdown of academic impact, for papers by Hironori Kusano Breakdown of academic impact, for papers by Shingo Kamoshida
Rankless by CCL
2026